Sorafenib Intermediate
have 1 Relevant products
Sorafenib (Developed And Sold Jointly By Bayer And Onyx Pharmac. Icals As Nexavar) Is A Kinase Inhibitor Approved For The Treatment Of Primary Renal Cancer (Advanced Renal Cell Carcinoma), Advanced Primary Liver Cancer (Hepatocellular Carcinoma) And Advan
